...
首页> 外文期刊>EBioMedicine >TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation
【24h】

TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation

机译:TGF-β-诱导的Transgelin通过调节上皮 - 间充质转换和invidopodia形成来促进膀胱癌转移

获取原文

摘要

Background Metastatic bladder cancer (BLCA) is a lethal disease with an unmet need for study. Transgelin (TAGLN) is an actin-binding protein that affects the dynamics of the actin cytoskeleton indicating its robust potential as a metastasis initiator. Here, we sought to explore the expression pattern of TAGLN and elucidate its specific functioning and mechanisms in BLCA. Methods A comprehensive assessment of TAGLN expression in BLCA was performed in three cohorts with a total of 847 patients. The potential effects of TAGLN on BLCA were further determined using clinical genomic analyses that guided the subsequent functional and mechanistic studies. In vitro migration, invasion assays and in vivo metastatic mouse model were performed to explore the biological functions of TAGLN in BLCA cells. Immunofluorescence, western blot and correlation analysis were used to investigate the molecular mechanisms of TAGLN. Findings TAGLN was highly expressed in BLCA and correlated with advanced prognostic features. TAGLN promoted cell colony formation and cell migration and invasion both in vitro and in vivo by inducing invadopodia formation and epithelial-mesenchymal transition, during which a significant correlation between TAGLN and Slug was observed. The progression-dependent correlation between TGF-β and TAGLN was analysed at both the cellular and tissue levels, while TGF-β-mediated migration was abolished by the suppression of TAGLN. Interpretation Overall, TAGLN is a promising novel prognosis biomarker of BLCA, and its metastatic mechanisms indicate that TAGLN may represent a novel target agent that can be utilized for the clinical management of invasive and metastatic BLCA. Fund This work was supported by the National Natural Science Foundation of China [ 81772703 , 81672546 , 81602253 ]; the Natural Science Foundation of Beijing [ 7172219 , 7152146 ] and Innovative Fund for Doctoral Students of Peking University Health Science Center ( BUM2018BSS002 ). Funders had no role in the design of the study, data collection, data analysis, interpretation, or the writing of this report.
机译:背景技术转移性膀胱癌(BLCA)是一种致命疾病,具有未满足的研究需求。转蛋白(Tagln)是一种肌动蛋白结合蛋白,其影响肌动蛋白细胞骨架的动力学,其表明其作为转移引发剂的稳健潜力。在这里,我们试图探索TAGLN的表达模式,并阐明其在BLCA中的特定功能和机制。方法在三个群组中综合评估BLCA中的表达,共有847名患者进行。使用引导随后的功能和机械研究的临床基因组分析进一步确定TAGLN对BLCA的潜在效果。体外迁移,侵袭测定和体内转移性小鼠模型进行探讨BLCA细胞中TAGLN的生物学功能。使用免疫荧光,Western印迹和相关分析来研究TAGLN的分子机制。发现TARLN在BLCA中高度表达并与高级预后特征相关联。通过诱导invidopodia形成和上皮 - 间充质转换,在体外和体内促进细胞污染物形成和细胞迁移和侵袭,在此期间观察到TAGLN和SLUG之间的显着相关性。在细胞和组织水平下分析了TGF-β和TAGLN之间的进展相关的相关性,而TGF-β-介导的迁移通过抑制TAGLN废除。总体上总体而言,Tagln是BLCA的有希望的新型预后生物标志物,其转移机制表明,TAGLN可以代表一种新的靶剂,可用于侵入性和转移性BLCA的临床管理。基金这项工作得到了中国国家自然科学基金的支持[81772703,81672546,81602253];北京自然科学基金[7172219,7152146]与北京大学卫生科学中心博士生的创新基金(BUM2018BSS002)。资助者在研究的设计中没有作用,数据收集,数据分析,解释或本报告的写作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号